BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33535844)

  • 1. A population-based study of the three major variants of papillary thyroid carcinoma.
    Xu J; Zhang Y; Liu J; Qiu S; Wang M
    J Int Med Res; 2021 Feb; 49(2):300060520984618. PubMed ID: 33535844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
    Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
    J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
    Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary Thyroid Carcinomas with Tall Cell Features: An Intermediate Entity Between Classic and Tall Cell Subtypes.
    Bikas A; Wong K; Pappa T; Ahmadi S; Wakefield CB; Marqusee E; Xiang P; Altshuler B; Haase J; Barletta JA; Landa I; Alexander EK
    Thyroid; 2023 Jun; 33(6):697-704. PubMed ID: 36960703
    [No Abstract]   [Full Text] [Related]  

  • 5. Classical and follicular variant papillary thyroid carcinoma: comparison of clinical, ultrasonographical, cytological, and histopathological features in 444 patients.
    Ozdemir D; Ersoy R; Cuhaci N; Arpaci D; Ersoy EP; Korukluoglu B; Guler G; Cakir B
    Endocr Pathol; 2011 Jun; 22(2):58-65. PubMed ID: 21556739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers.
    Ertek S; Yılmaz NC; Cicero AF; Vurupalmaz Ö; Demiröz AS; Erdoğan G
    Endocr Pathol; 2012 Sep; 23(3):157-60. PubMed ID: 22711546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
    Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
    Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
    Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
    Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
    Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.
    Sullivan MC; Graham PH; Alexander EK; Ruan DT; Nehs MA; Gawande AA; Moore FD; Howitt BE; Strickland KC; Krane JF; Barletta JA; Cho NL
    J Am Coll Surg; 2017 Jun; 224(6):1021-1027. PubMed ID: 28017809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer.
    Scholfield DW; Fitzgerald CW; Alzumaili B; Eagan A; Xu B; Martinez G; Tuttle RM; Shaha AR; Shah JP; Wong RJ; Patel SG; Ghossein RA; Ganly I
    Ann Surg Oncol; 2023 Aug; 30(8):4761-4770. PubMed ID: 37154968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Treatment and Prognosis Between Follicular Variant Papillary Thyroid Carcinoma and Classical Papillary Thyroid Carcinoma.
    Zhang B; Wu W; Liu J; Liang Z; Zong L
    Horm Metab Res; 2023 Dec; 55(12):855-868. PubMed ID: 37813352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
    Feng J; Shen F; Cai W; Gan X; Deng X; Xu B
    Endocrine; 2018 Sep; 61(3):499-505. PubMed ID: 29909599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
    Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography.
    Chai YJ; Kim SJ; Kim SC; Koo do H; Min HS; Lee KE; Kim JH; Youn YK
    Clin Endocrinol (Oxf); 2014 Sep; 81(3):432-9. PubMed ID: 24548081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma.
    John D; Yalamarty R; Barakchi A; Chen T; Chakladar J; Li WT; Ongkeko WM
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP).
    Strickland KC; Eszlinger M; Paschke R; Angell TE; Alexander EK; Marqusee E; Nehs MA; Jo VY; Lowe A; Vivero M; Hollowell M; Qian X; Wieczorek T; French CA; Teot LA; Cibas ES; Lindeman NI; Krane JF; Barletta JA
    Endocr Pathol; 2018 Mar; 29(1):68-74. PubMed ID: 29396809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutation of RAS gene in follicular-differentiated thyroid tumors and its significance].
    Liu LP; Hao JY; Pan H; Wang C; Yue P
    Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):256-261. PubMed ID: 32187898
    [No Abstract]   [Full Text] [Related]  

  • 19. Sonographic differences between conventional and follicular variant papillary thyroid carcinoma.
    Hughes NM; Nae A; Barry J; Fitzgerald B; Feeley L; Sheahan P
    Eur Arch Otorhinolaryngol; 2017 Jul; 274(7):2907-2913. PubMed ID: 28396943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.
    Liu Z; Zeng W; Chen T; Guo Y; Zhang C; Liu C; Huang T
    Oncotarget; 2017 Jan; 8(4):6222-6232. PubMed ID: 28009980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.